See more : Inhibrx Biosciences, Inc. (INBX) Income Statement Analysis – Financial Results
Complete financial analysis of Boliden AB (publ) (BOLIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Boliden AB (publ), a leading company in the Industrial Materials industry within the Basic Materials sector.
- Groupe CIOA (MLCIO.PA) Income Statement Analysis – Financial Results
- Poseida Therapeutics, Inc. (PSTX) Income Statement Analysis – Financial Results
- Banestes S.A – Banco do Estado do Espírito Santo (BEES4.SA) Income Statement Analysis – Financial Results
- General Mills, Inc. (GRM.DE) Income Statement Analysis – Financial Results
- Airbus SE (AIR.DE) Income Statement Analysis – Financial Results
Boliden AB (publ) (BOLIF)
About Boliden AB (publ)
Boliden AB (publ) engages in the exploring, extracting, and processing of base metals and precious metals in Sweden, other Nordic region, Germany, the United Kingdom, the rest of Europe, North America, and internationally. The company operates through two segments, Business Area Mines and Business Area Smelters. It explores for copper, zinc, nickel, lead, gold, silver, cobalt, tellurium, platinum, and palladium deposits. The company operates the Aitik, the Boliden Area, and Garpenberg mines in Sweden; the Tara mine in Ireland; and the Kevitsa mines in Finland. Its products include zinc and lead ingot, copper cathode, gold bar, and silver granule, and other products, such as sulphuric acid; copper, lead, nickel, and zinc concentrates; and by-products, including copper sulphate, zinc clinker, iron sand, copper telluride, selenium, nickel matte, and crude nickel sulphate, as well as palladium, platinum, rhodium, iridium, ruthenium, and osmium concentrates. The company sells its metals primarily to industrial customers, as well as construction, electronics, and automotive industries; and paper manufacturers. Boliden AB (publ) was founded in 1924 and is headquartered in Stockholm, Sweden.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.28B | 7.59B | 6.85B | 5.33B | 5.92B | 6.04B | 4.43B | 4.77B | 4.71B | 5.35B | 6.14B |
| Cost of Revenue | 6.55B | 6.16B | 5.53B | 4.33B | 4.71B | 4.75B | 3.64B | 4.19B | 4.21B | 4.89B | 5.31B |
| Gross Profit | 1.74B | 1.43B | 1.31B | 1.01B | 1.21B | 1.29B | 785.12M | 579.16M | 509.44M | 465.09M | 835.78M |
| Gross Profit Ratio | 20.99% | 18.84% | 19.18% | 18.85% | 20.39% | 21.29% | 17.74% | 12.15% | 10.80% | 8.69% | 13.60% |
| Research & Development | 102.46M | 108.12M | 91.04M | 79.55M | 82.48M | 84.48M | 61.37M | 61.13M | 50.10M | 63.00M | 65.89M |
| General & Administrative | 97.09M | 68.43M | 82.05M | 73.47M | 73.11M | 55.10M | 66.64M | 67.40M | 68.89M | 81.66M | 82.16M |
| Selling & Marketing | 62.39M | 57.04M | 61.38M | 51.90M | 49.42M | 50.83M | 42.82M | 42.76M | 43.58M | 52.89M | 59.13M |
| SG&A | 161.31M | 127.02M | 145.14M | 127.50M | 124.67M | 108.13M | 111.99M | 113.96M | 116.94M | 141.86M | 143.60M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 224.56M | 218.11M | 245.78M | 209.08M | 203.87M | 200.41M | 182.58M | 167.50M | 176.24M | 207.35M | 211.32M |
| Cost & Expenses | 6.77B | 6.38B | 5.78B | 4.54B | 4.92B | 4.95B | 3.82B | 4.36B | 4.38B | 5.09B | 5.52B |
| Interest Income | 19.36M | 12.93M | 13.98M | 12.81M | 13.88M | 19.75M | 12.41M | 14.10M | 17.25M | 11.67M | 11.36M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 580.53M | 611.77M | 681.07M | 532.84M | 552.50M | 556.00M | 457.28M | 414.38M | 417.42M | 439.11M | 379.95M |
| EBITDA | 2.05B | 1.80B | 1.72B | 1.31B | 1.54B | 1.64B | 1.06B | 828.99M | 760.32M | 704.79M | 1.02B |
| EBITDA Ratio | 24.77% | 23.70% | 25.18% | 24.51% | 25.98% | 27.08% | 24.01% | 17.39% | 16.13% | 13.17% | 16.57% |
| Operating Income | 1.47B | 1.19B | 1.04B | 774.06M | 985.19M | 1.08B | 605.61M | 414.61M | 342.90M | 265.68M | 638.12M |
| Operating Income Ratio | 17.76% | 15.64% | 15.23% | 14.52% | 16.65% | 17.87% | 13.68% | 8.70% | 7.27% | 4.96% | 10.39% |
| Total Other Income/Expenses | 23.96M | 11.83M | 10.94M | 9.29M | 3.50M | -7.79B | -4.93B | -3.10B | -26.97M | -19.60M | -25.03M |
| Income Before Tax | 1.50B | 1.20B | 1.05B | 783.35M | 988.68M | 1.07B | 590.13M | 397.55M | 315.94M | 246.08M | 613.09M |
| Income Before Tax Ratio | 18.05% | 15.79% | 15.39% | 14.69% | 16.71% | 17.64% | 13.33% | 8.34% | 6.70% | 4.60% | 9.98% |
| Income Tax Expense | 305.84M | 236.02M | 226.94M | 165.30M | 176.23M | 229.30M | 124.61M | 84.70M | 73.11M | 44.80M | 99.98M |
| Net Income | 1.19B | 961.88M | 826.44M | 617.84M | 812.11M | 835.53M | 465.19M | 312.74M | 242.58M | 200.81M | 512.80M |
| Net Income Ratio | 14.36% | 12.68% | 12.07% | 11.59% | 13.72% | 13.84% | 10.51% | 6.56% | 5.14% | 3.75% | 8.35% |
| EPS | 4.35 | 3.52 | 3.02 | 2.26 | 2.97 | 3.05 | 1.70 | 1.14 | 0.89 | 0.73 | 1.87 |
| EPS Diluted | 4.35 | 3.52 | 3.02 | 2.26 | 2.97 | 3.05 | 1.70 | 1.14 | 0.89 | 0.73 | 1.87 |
| Weighted Avg Shares Out | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M |
| Weighted Avg Shares Out (Dil) | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M | 273.51M | 273.53M | 273.58M | 273.51M | 273.52M | 273.51M |
Source: https://incomestatements.info
Category: Stock Reports